Edward Alvin Greenfield

USPTO Granted Patents = 17 (Patent Applications = 14)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 5.4

ph-index = 8

Forward Citations = 373(Granted Patents)

Location History:

Randolph, MA (US) (2000 - 2009)
Stoughton, MA (US) (2001 - 2024)

Company Filing History:

6 out of 1,206

Dana-farber-cancer Institute Inc.

patents

5 out of 1,370

The Brigham and Women's Hospital, Inc.

Millennium Pharmaceuticals Limited

patents

6. 2 out of 2

Amgen British Columbia Inc.

patents

7. 1 out of 1

Replingen Corporation

patent

8. 1 out of 389

Genetics Institute, Inc.

patents

9. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2025

Loading Chart...

17 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12247974 - Device and method for chemical analysis (2025-03-11),

2. 12055543 - Methods and devices for detection of THC (2024-08-06),

3. 11209416 - Device and method for chemical analysis (2021-12-28),

4. 11149318 - Methods and devices for detection of pathogens (2021-10-19),

5. 10941211 - Anti-GCC antibody molecules and related compositions and methods (2021-03-09),

6. 10782285 - Device and method for chemical analysis (2020-09-22),

7. 10401352 - Device and method for chemical analysis (2019-09-03),

8. 9664674 - Device and method for chemical analysis (2017-05-30),

9. 9333256 - Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cells (2016-05-10),

10. 8785600 - Anti-GCC antibody molecules and related compositions and methods (2014-07-22),

11. 8697069 - Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cells (2014-04-15),

12. 8101176 - Compositions and methods related to TIM-3, a TH1-specific cell surface molecule (2012-01-24),

13. 7592007 - Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies (2009-09-22),

14. 7470428 - Compositions and methods related to TIM-3, a Th1-specific cell surface molecule (2008-12-30),

15. 6719972 - Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA4- specific antibodies (2004-04-13),

Title: The Innovative Contributions of Edward Alvin Greenfield

Introduction

Edward Alvin Greenfield is a notable inventor based in Stoughton, MA, with a remarkable portfolio of 17 patents. His work primarily focuses on advancements in chemical analysis and detection methods, showcasing his commitment to innovation in the field.

Latest Patents

Among his latest inventions is a device and method for chemical analysis, which includes a processing and detection system designed to identify gluten proteins in food samples. This system features a food processor that processes the sample and generates a processed food liquid, which is then analyzed for gluten content. Another significant patent involves methods and devices for detecting tetrahydrocannabinol (THC) in samples. This method utilizes a graphene layer functionalized with an antibody specific to THC, allowing for the detection of THC through changes in electrical resistance.

Career Highlights

Throughout his career, Edward has worked with prestigious institutions such as Dana-Farber Cancer Institute and Brigham and Women's Hospital. His contributions to these organizations have furthered research and development in medical and analytical technologies.

Collaborations

Edward has collaborated with notable professionals in his field, including Gordon James Freeman and Mohammad Esmaail Taslim. These partnerships have enhanced his research and innovation efforts.

Conclusion

Edward Alvin Greenfield's inventive spirit and dedication to advancing chemical analysis technologies have made a significant impact in his field. His patents reflect a commitment to improving detection methods, which can benefit various industries.

This text is generated by artificial intelligence and may not be accurate.